live attenuated influenza vaccine
GPTKB entity
Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:administeredBy |
intranasal spray
|
| gptkbp:age |
2 to 49 years
|
| gptkbp:approvedBy |
gptkb:FDA
2003 |
| gptkbp:brand |
gptkb:FluMist
|
| gptkbp:broadcastOn |
annual
|
| gptkbp:contains |
gptkb:live_attenuated_influenza_virus
|
| gptkbp:contraindication |
severe egg allergy
severe allergic reaction to previous influenza vaccine asthma in children under 5 |
| gptkbp:developedBy |
gptkb:MedImmune
|
| https://www.w3.org/2000/01/rdf-schema#label |
live attenuated influenza vaccine
|
| gptkbp:notRecommendedFor |
pregnant women
immunocompromised individuals children under 2 years adults over 49 years |
| gptkbp:sideEffect |
headache
cough sore throat runny nose |
| gptkbp:storage |
refrigerated
|
| gptkbp:usedFor |
prevention of influenza
|
| gptkbp:WHOStatus |
gptkb:World_Health_Organization_Model_List_of_Essential_Medicines
|
| gptkbp:bfsParent |
gptkb:Seasonal_influenza
|
| gptkbp:bfsLayer |
5
|